SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 208.79 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 487.21 |
| Book Value / Share | 3.08 |
| Price / Book | n/a |
| NCAV ($M) | -135.91 |
| NCAV / Share | -0.86 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.71 |
| Return on Assets (ROA) | -0.46 |
| Return on Equity (ROE) | -1.20 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.10 |
| Current Ratio | 3.12 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 294.57 |
| Assets | 917.70 |
| Liabilities | 430.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 269.00 |
| Operating Income | -85.91 |
| Net Income | -598.12 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -165.75 |
| Cash from Investing | -47.79 |
| Cash from Financing | 148.66 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 9,698,668 | 17,107,535 | 56.69 | |
| 1,554,103 | 4,546,755 | 34.18 | |
| 1,294,574 | 3,940,012 | 32.86 | |
| 3,409,902 | 9,012,363 | 37.84 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BPMC – Blueprint Medicines Corporation | CABA – Cabaletta Bio, Inc. |
| CCCC – C4 Therapeutics, Inc. | CGEM – Cullinan Therapeutics, Inc. |
| CGON – CG Oncology, Inc. |